ArticleInternational journal of molecular sciences2022

Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling.

Stephen M Stahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.